Literature DB >> 1356600

Iontophoretic effects of sigma ligands on rubral neurons in the rat.

R R Matsumoto1, J M Walker.   

Abstract

Iontophoretic application of the sigma ligands, 1,3-di-o-tolylguanidine (DTG), dextrallorphan, and (+)-pentazocine reliably inhibited the firing rate of rubral neurons. Dextrallorphan inhibited 87% of the neurons tested, DTG inhibited 76%, and (+)-pentazocine inhibited 50%. These inhibitions were current dependent and occurred without significant changes in spike amplitude or duration, suggesting that local anesthetic effects were not involved. In contrast to the other sigma ligands, iontophoretic application of (+)-3-PPP in the rat red nucleus resulted in very few inhibitions and tended to elicit weak excitations instead. Only 14% of rubral neurons were inhibited by (+)-3PPP, while 36% were excited. Although unusual, (+)-3-PPP has atypical effects when compared to other sigma ligands in numerous functional assays for sigma receptor activity. (+)-3-PPP, therefore, appears to have complex effects and may act through nonsigma mechanisms or through a different type of sigma binding site than the other compounds. The inhibition of firing rate produced by the more typical sigma ligands may contribute to the postural changes produced by microinjection of sigma ligands into the rat red nucleus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356600     DOI: 10.1016/0361-9230(92)90078-c

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  3 in total

1.  Intracellular sigma1 receptor modulates phospholipase C and protein kinase C activities in the brainstem.

Authors:  M P Morin-Surun; T Collin; M Denavit-Saubié; E E Baulieu; F P Monnet
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 2.  Animal models of focal dystonia.

Authors:  Craig Evinger
Journal:  NeuroRx       Date:  2005-07

Review 3.  Animal models for dystonia.

Authors:  Bethany K Wilson; Ellen J Hess
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.